ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

In Brief: Joseph Bertino Succeeds Bresnick As AACR President; Louise Strong Is President-Elect

March 31, 1995

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981